July 22, 2026

Medical Oddities: When AI Meets the Afterlife

Ghosts, germs, B cells, and brews—this week's research is anything but ordinary.

Conexiant

July 22, 2026

Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records

“Clearly, this administration has not earned our trust with Americans’ sensitive data."

Conexiant

July 20, 2026

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.

Conexiant

July 16, 2026

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

Voters will decide whether to expand lawmakers' authority to tax currently exempt healthcare goods and services, raising concerns about patient costs and healthcare access.

Kff Health News

July 16, 2026

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

Conexiant

July 15, 2026

Low IMA Ligation Did Not Significantly Reduce Leaks

A randomized trial found similar short-term morbidity and 12-month functional outcomes with both approaches, while highlighting the need to balance perfusion with a tension-free anastomosis.

Conexiant

July 14, 2026

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

Conexiant

July 13, 2026

New CDC Report Tracks US Mortality Trends

The annual provisional report summarizes changes in mortality rates, demographic patterns, and leading causes of death during 2025.

Conexiant

July 10, 2026

FDA Expands Bladder Cancer Regimen

KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.

Conexiant

July 10, 2026

FDA Approves Subcutaneous Isatuximab-irfc

The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.

Conexiant